creative-biolabs.com has been visited by 10K+ users in the past month
Comprehensive Viral Vaccines Development Services to Accelerate Your Researches. Save Time. Several Experienced Vaccine Experts Provide supports for your research. Contact us today
- Vaccine Service
Vaccine Development Service
Vaccine Development and Production
- Vaccine Design
Provides the most comprehensive
services for retro-viral ...
- Fungal Vaccines
High-quality Fungal Vaccines
Multiple Fungal Vaccines
- HPV Vaccines
HPV Vaccines development
HPV related disease Vaccine service
- AID Vaccines
Autoimmune Disease Vaccines
AID Disease Vaccines development
- Bacterial Vaccines
High-quality Bacterial Vaccines
Multiple Bacterial Vaccine
- Vaccine Service
Search results
Apr 3, 2022 · NHS rolls out COVID vaccine to five million 5 to 11 year olds. The NHS will start vaccinating children aged 5-11 today, as the biggest and most successful vaccination drive in health service history moves to the next phase. Almost five million children in this age group are eligible for two doses of the vaccine following updated JCVI guidance ...
Sep 2, 2021 · Half of all 16 and 17-year-olds receive life-saving COVID vaccine. 2 September 2021. Children and young people. Coronavirus. New figures show 50% of all teens aged 16 and 17 have had their first COVID jab, just four weeks after the green light was given for this age group.
- Advice
- Considerations
- Vaccine Safety and Efficacy
- Key Evidence Considered
Primary vaccination of 5 to 11 year olds
Children aged 5 to 11 years in a clinical risk group (as defined in the Green Book), or who are a household contact of someone who is immunosuppressed (as defined in the Green Book), should be offered two 10 micrograms doses of the Pfizer-BioNTech COVID-19 vaccine (Comirnaty®) with an interval of 8 weeks between the first and second doses. The minimum interval between any vaccine dose and recent COVID-19 infection should be 4 weeks. Further advice regarding COVID-19 vaccination for other 5 to...
Booster vaccination of 12 to 17 year olds
The following cohorts of children and young people should be offered a booster dose of 30 micrograms Pfizer-BioNTech COVID-19 vaccine (Comirnaty®) no sooner than 3 months after completion of their primary course: 1. children and young people aged 16 to 17 years 2. children and young people aged 12 to 15 who are in a clinical risk group or who are a household contact of someone who is immunosuppressed 3. children and young people aged 12 to 15 years who are severely immunosuppressed and who ha...
Primary vaccination of 5 to 11 year olds
When formulating advice in relation to childhood immunisations, JCVI has consistently held that the main focus of its considerations should be the potential benefits and harms of vaccination to children and young people themselves. The benefits and risks from COVID-19 vaccination in children and young people are finely balanced largely because the risks associated with SARS-CoV2 infection are very low. Of all age groups, children aged 5 to 11 years are those at lowest risks of serious COVID-1...
In a clinical trial of 2268 children aged 5 to 11 years randomised to receive 2 doses of 10 micrograms Pfizer-BioNTech COVID-19 vaccine or placebo, the vaccine was found to be safe and immunogenic.[footnote 2] Immune responses in vaccinated 5 to 11 year olds were at least as good as those measured in 15 to 25 year olds who received 30 micrograms of...
Risk of myocarditis following vaccination
1. MHRA reports of suspected myocarditis following vaccination(and unpublished data) 2. CDC reports of myocarditis following vaccination(and unpublished data) 3. Reported side effects following COVID-19 vaccination in Canada 4. Public Health Ontario data on myocarditis following vaccination(and unpublished data) 5. Buchan and others. Epidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario, Canada: by vaccine product, schedule and interval 6. NORDIC data on myocarditis...
Risk of myocarditis following infection
1. Patone and others, Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection 2. Singer and others, Risk of myocarditis from COVID-19 infection in people under age 20: a population-based analysis 3. Patel T and others, Comparison of MIS-C related myocarditis, classic viral myocarditis, and COVID-19 vaccine related myocarditis in children.
Vaccine efficacy and effectiveness against infection, symptomatic disease, hospitalisation and mortality
1. Walter and others, Evaluation of the BNT162b2 COVID-19 vaccine in children 5 to 11 years of age 2. UKHSACOVID-19 weekly vaccine surveillance reports 3. Frenck and others, Safety, immunogenicity, and efficacy of the BNT162b2 COVID-19 vaccine in adolescents 4. Miron O and others, Effectiveness of COVID-19 vaccine BNT162b2 at age 12 to 15 years with one dose (Israel) 5. Andrews N and others, Vaccine effectiveness and duration of protection of Comirnaty, Vaxzevria and Spikevax against mild and...
Feb 16, 2022 · Coronavirus vaccine for children and young people, aged 12 to 15 who are most likely to get very poorly from coronavirus. This information is for children and young people and their...
- You will need to have 2 vaccines to keep you as safe as possible.The second vaccine should be 8 to 12 weeks after your first vaccine. 8 to 12 weeks...
- You and your parent or carer will get a letter or a phone call to invite you for your vaccine.If you have not had a letter or a phone call you or y...
- You can talk to the nurse or doctor who will give you your vaccine, about any support that will help make it easier for you.This is sometimes calle...
- Your arm might feel heavy or sore.Your body might ache.You might feel like you have a cold or the flu.You might have a headache.You might feel tire...
- Wash your hands or use hand sanitiser lots. This is important when you are out and when you have just come home.You don’t have to wear a mask, but...
- There is more information on coronavirus on the NHS website.You can also get more coronavirus information by phoning 111.
Feb 1, 2022 · The NHS is offering COVID-19 vaccine to some children and young people. This includes those aged 12 to 17 years who need 2 doses of the vaccine 12 weeks apart or 8 weeks apart if at...
Nov 7, 2023 · A COVID-19 vaccine might prevent your child from getting the virus that causes COVID-19. It also may prevent your child from becoming seriously ill or having to stay in the hospital due to the COVID-19 virus.
Sep 12, 2023 · Children aged 6 months–4 years who got COVID-19 vaccines before September 12, 2023, should get one or two doses of an updated Pfizer-BioNTech or Moderna vaccine. Talk with your healthcare provider about the recommended dose.
